Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
36,048,259
-
Share change
-
+948,451
-
Total reported value
-
$229,963,501
-
Put/Call ratio
-
52%
-
Price per share
-
$6.38
-
Number of holders
-
159
-
Value change
-
+$8,627,432
-
Number of buys
-
90
-
Number of sells
-
80
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2025
As of 30 Jun 2025,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,048,259 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, AMERICAN CENTURY COMPANIES INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, PALISADE CAPITAL MANAGEMENT, LP, MARSHALL WACE, LLP, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
159
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.